Sector News

Chiltern PCR buy cements Asia-Pacific offering

September 30, 2014
Life sciences
Chiltern has made its second significant acquisition this year snapping up fellow contract research organisation Pacific Clinical Research in a move designed to secure a stronger foothold in the Asia-Pacific region.
 
The London, UK and Wilmington, NC-based group says the addition of PCR will allow it to offer integrated services throughout the Asia-Pacific (APAC) region and strengthens in particular its offering within oncology and anti-infective areas.
 
Chiltern has been considering a means of growing capabilities in APAC for some time, because there is great interest across the industry to place more clinical trials in the region, a company spokesman told PharmaTimes.
 
“We are seeing APAC regularly in RFIs [request for information] and RFPs [request for proposal] from current and prospective customers, so this puts us in a more competitive position as a truly global service provider”, he explained. 
 
Terms of the acquisition, which follows Chiltern’s summer purchase of specialist oncology and resourcing CRO Ockham, are being kept under wraps.
 
The firm now has over 2,200 staff working across 45 countries and while no other strategic changes are immediately expected, “we are always looking for ways to improve our business and will consider other opportunities that align with the needs of our customers,” the spokesman said.
 
By Selina McKee
 
Source: Pharma Times

Related News

April 10, 2021

Genentech aims high with new diversity goals, including doubling hires and spending $1B with diverse suppliers

Life sciences

Quita Highsmith, Genentech’s chief diversity officer, is helping the pharma double down on diversity and inclusion goals with a new 2025 plan. 

April 10, 2021

Merck CEO Frazier joins army of Black execs speaking out on restrictive voting-rights laws

Life sciences

Merck CEO Kenneth Frazier teamed up with former American Express executive Kenneth Chenault to protest a voting-rights law passed recently in Georgia.

April 10, 2021

Zimmer Biomet bundles robotic surgery, apps and digital health programs into one orthopedics package

Life sciences

By bringing together big data and robotic procedures, the ultimate goal of the connected suite is to take some of the guesswork out of orthopedic medicine. 

Send this to a friend